MedPath

Colonoscopic surveillance using narrow-band imaging in patients with hyperplastic polyposis syndrome (HPS)

Conditions
polyps
tumor
10018018
10017990
Registration Number
NL-OMON30966
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

All patients presenting, or under surveillance at the Endoscopy Department of the AMC with:
1) *10 HPs found at colonoscopy, or
2) *5 HPs proximal to the sigmoid colon, or
3) Any number of HPs occurring proximal to sigmoid colon in an individual who has a first-degree relative with HPS

Exclusion Criteria

1) history of inflammatory bowel disease, 2) severe coagulopathy, 3) age less than 18 years and 4) insufficient bowel preparation (<90% of colonic mucosa visible).

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The sensitivity of WLE will be compared to that of NBI for the detection of<br /><br>polyps and cancer in the colon. The sensitivity of each technique will be<br /><br>calculated as the number of lesions detected during the first inspection,<br /><br>divided by the total number of lesions detected by both inspections.<br /><br>Furthermore, the surface pit pattern of the detected lesions on NBI will be<br /><br>used to obtain the overall accuracy (representing sensitivity and specificity)<br /><br>of this technique, by using the histological diagnosis as the gold standard<br /><br>diagnosis. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Moreover, the prevalence and distribution of HPs, SAs, MPs and adenomas in this<br /><br>patient population will be described.</p><br>
© Copyright 2025. All Rights Reserved by MedPath